US equities |
MU $1,029.00 ▼-0.66% NVDA $229.28 ▼-0.52% SPCX $162.57 ▲+1.25% TSLA $382.70 ▲+2.05% AAPL $336.64 ▼-1.11% MSFT $535.07 ▲+2.38% AMZN $262.43 ▲+3.29% META $718.67 ▼-0.31%
FinancialContent

Cibus, Inc. - Class A Common Stock (NQ:CBUS)

1.550 -0.040 (-2.52%)
Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cibus, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Cibus, Inc. Announces Proposed Public Offering of Class A Common Stock
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus and Interoc Advance Rice Commercialization Strategy for Herbicide-Tolerant Traits in Key Markets across Latin America
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus Welcomes the Positive Conclusion of Trilogue Negotiations on New Genomic Techniques Legislation Between the European Parliament and Council
From Cibus US LLC
Via GlobeNewswire
News headline image
Earnings Scheduled For November 13, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 14, 2025 ↗
 
Via Benzinga
News headline image
Cibus Inc (NASDAQ:CBUS) Reports Q3 2025 Earnings Miss on Revenue, Narrower Loss ↗
Cibus (CBUS) Q3 2025 results show a narrower loss but a revenue miss, sending shares lower. The company highlights progress on key rice traits and cost-saving initiatives. 
Via Chartmill
Topics Earnings
News headline image
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
Cibus Reports Third Quarter Financial Results and Provides Year-to-Date Business Update for 2025
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus Announces the Election of Craig Wichner to Board of Directors
Appointment underscores company’s commitment to long-term shareholder value creation and sustained business growth 
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus to Report Third Quarter 2025 Financial Results on November 13, 2025 After the Market Close and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus and AgVayā Collaborate to Introduce Indian Rice Growers to New Solutions to Scale Crop Productivity Through Advanced Gene Editing
Collaboration aims to accelerate the adoption of advanced gene editing technologies in and deliver high-performance traits that support more sustainable and productive rice production in India 
From Cibus US LLC
Via GlobeNewswire
News headline image
Soybean Short Squeeze: Cooking Oil Stocks Pop After Trump Targets China ↗
Soybean-related stocks exploded on Wednesday following President Donald Trump's latest comments in the ongoing trade war with China. 
Via Benzinga
Topics Government World Trade
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Veritone Shares Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
What's Driving Cibus Inc.'s Pre-Market Surge Amid Trump's China Trade Warning? ↗
CBUS stock surged 23.81% in pre-market trading following Trump's trade escalation with China, causing gains in agricultural stocks. 
Via Benzinga
Topics Government
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
Cibus Announces Positive Field Trial Results for Second-Generation Herbicide Tolerance (HT2) Edited Canola
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus Announces the Election of Kimberly A. Box to Board of Directors
Appointment strengthens governance and commercialization strategy expertise as Cibus continues preparations for launch of its advanced trait technologies delivering crop productivity and sustainability... 
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus CEO to Highlight Gene Editing’s Role in Building Resilient Agriculture at UN Climate Week 2025
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus’ Herbicide Tolerance Trait
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus Inc (NASDAQ:CBUS) Q2 2025 Earnings: Revenue Misses but Loss Narrower Than Expected ↗
Cibus Inc (CBUS) reports Q2 2025 earnings with revenue missing estimates at $930K but a narrower loss of -$0.61 per share. Progress in gene-edited crops and cost cuts offer optimism. 
Via Chartmill
News headline image
Cibus Reports Second Quarter Financial Results and Provides Year-to-Date Business Update for 2025
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus to Report Second Quarter 2025 Financial Results on August 14, 2025 After the Market Close and Host Conference Call
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus Announces Steps to Implement More Streamlined Business Focus on its Nearest Term Revenue Opportunities
From Cibus US LLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
The U.S. Food and Drug Administration Completes Review of Cibus’ Altered Lignin Alfalfa Developed in Partnership with S&W Seed Company for use in Livestock Feed
Completion of the U.S. Food and Drug Administration’s Plant Biotechnology Consultation Program enables U.S. commercialization of alfalfa with an altered lignin profile offering potential improved... 
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus and John Innes Centre Announce Ongoing Collaboration with Potential to Revolutionize Fertilizer Use in Farming
From Cibus US LLC
Via GlobeNewswire
News headline image
Cibus, Inc. Announces Closing of $27.5 Million Public Offering
From Cibus US LLC
Via GlobeNewswire
News headline image
USDA Designates Cibus’ Herbicide Tolerance Canola Trait HT2 as Not Regulated Under USDA’s Biotechnology Regulations
This action follows the USDA’s recent designation of Cibus’ disease resistance traits in Canola as not regulated, continuing Cibus’ product development momentum in the globally important Canola crop 
From Cibus US LLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >